Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 3/2010

Open Access 01-06-2010 | Research article

Biomechanical modulation of collagen fragment-induced anabolic and catabolic activities in chondrocyte/agarose constructs

Authors: Tina T Chowdhury, Ronny M Schulz, Sonpreet S Rai, Christian B Thuemmler, Nico Wuestneck, Augustinus Bader, Gene A Homandberg

Published in: Arthritis Research & Therapy | Issue 3/2010

Login to get access

Abstract

Introduction

The present study examined the effect of collagen fragments on anabolic and catabolic activities by chondrocyte/agarose constructs subjected to dynamic compression.

Methods

Constructs were cultured under free-swelling conditions or subjected to continuous and intermittent compression regimes, in the presence of the N-terminal (NT) and C-terminal (CT) telopeptides derived from collagen type II and/or 1400 W (inhibits inducible nitric oxide synthase (iNOS)). The anabolic and catabolic activities were compared to the amino-terminal fibronectin fragment (NH2-FN-f) and assessed as follows: nitric oxide (NO) release and sulphated glycosaminoglycan (sGAG) content were quantified using biochemical assays. Tumour necrosis factor-α (TNFα) and interleukin-1β (IL-1β) release were measured by ELISA. Gene expression of matrix metalloproteinase-3 (MMP-3), matrix metalloproteinase-13 (MMP-13), collagen type II and fibronectin were assessed by real-time quantitative polymerase chain reaction (qPCR). Two-way ANOVA and the post hoc Bonferroni-corrected t-test was used to examine data.

Results

The presence of the NT or CT peptides caused a moderate to strong dose-dependent stimulation of NO, TNFα and IL-1β production and inhibition of sGAG content. In some instances, high concentrations of telopeptides were just as potent in stimulating catabolic activities when compared to NH2-FN-f. Depending on the concentration and type of fragment, the increased levels of NO and cytokines were inhibited with 1400 W, resulting in the restoration of sGAG content. Depending on the duration and type of compression regime employed, stimulation with compression or incubation with 1400 W or a combination of both, inhibited telopeptide or NH2-FN-f induced NO release and cytokine production and enhanced sGAG content. All fragments induced MMP-3 and MMP-13 expression in a time-dependent manner. This effect was reversed with compression and/or 1400 W resulting in the restoration of sGAG content and induction of collagen type II and fibronectin expression.

Conclusions

Collagen fragments containing the N- and C-terminal telopeptides have dose-dependent catabolic activities similar to fibronectin fragments and increase the production of NO, cytokines and MMPs. Catabolic activities were downregulated by dynamic compression or by the presence of the iNOS inhibitor, linking reparative activities by both types of stimuli. Future investigations which examine the signalling cascades of chondrocytes in response to matrix fragments with mechanical influences may provide useful information for early osteoarthritis treatments.
Appendix
Available only for authorised users
Literature
1.
Homandberg GA: Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Fundamental Pathways in Osteoarthritis Front Biosci. Edited by: Malemud CJ. 1997, 713-730.
2.
3.
Homandberg GA, Ding L, Guo D: Extracellular matrix fragments as regulators of cartilage metabolism in health and disease. Curr Rheumatol Rev. 2007, 3: 183-196. 10.2174/157339707781387590.CrossRef
4.
Lorenzo P, Bayliss MT, Heinegard D: Altered patterns and synthesis of extracellular matrix macromolecules in early OA. Matrix Biol. 2004, 23: 381-391. 10.1016/j.matbio.2004.07.007.CrossRefPubMed
5.
Griffin TM, Guilak F: The role of mechanical loading in the onset and progression of osteoarthritis. Exerc Sport Sci Rev. 2005, 33: 195-200. 10.1097/00003677-200510000-00008.CrossRefPubMed
6.
Guilak F, Fermor B, Keefe FJ, Kraus VB, Olson SA, Pisetsky DS, Setton LA, Weinberg JB: The role of biomechanics and inflammation in cartilage repair and injury. Clin Orthop Relat Res. 2004, 17-26. 10.1097/01.blo.0000131233.83640.91.
7.
Loeser RF: Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide. Arthritis Rheum. 2006, 54: 1357-1360. 10.1002/art.21813.PubMedCentralCrossRefPubMed
8.
Xie D, Hui F, Homandberg GA: Fibronectin fragments alter matrix protein synthesis in cartilage tissue cultured in vitro. Arch Biochem Biophys. 1993, 307: 110-118. 10.1006/abbi.1993.1568.CrossRefPubMed
9.
Xie D, Hui F, Homandberg GA: Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Arch Biochem Biophys. 1994, 311: 205-212. 10.1006/abbi.1994.1228.CrossRefPubMed
10.
Homandberg GA, Hui F: Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch Biochem Biophys. 1996, 334: 325-331. 10.1006/abbi.1996.0461.CrossRefPubMed
11.
Homandberg GA, Hui F, Wen C, Purple C, Bewsey K, Koepp H, Huch K, Harris A: Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J. 1997, 321: 751-757.PubMedCentralCrossRefPubMed
12.
Homandberg GA, Wen C, Hui F: Cartilage damaging activities of the fibronectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage. 1998, 6: 231-244. 10.1053/joca.1998.0116.CrossRefPubMed
13.
Gemba T, Valbracht J, Alsalmeh S, Lotz M: Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment. J Biol Chem. 2002, 277: 907-911. 10.1074/jbc.M109690200.CrossRefPubMed
14.
Pichika R, Homandberg GA: Fibronectin fragments elevate nitric oxide (NO) and inducible NO synthetase (iNOS) levels in bovine cartilage and iNOS inhibitors block fibronectin fragment mediated damage and promote repair. Inflamm Res. 2004, 53: 405-412. 10.1007/s00011-004-1279-8.CrossRefPubMed
15.
Forsyth CB, Pulai J, Loeser RF: Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum. 2002, 46: 2368-2376. 10.1002/art.10502.CrossRefPubMed
16.
Homandberg GA, Meyers R, Xie D: Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem. 1992, 267: 3597-3604.PubMed
17.
Yasuda T, Kakinuma T, Julovi SM, Yoshida M, Hiramitsu T, Akiyoshi M, Nakamura T: COOH-terminal heparin-binding fibronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44. Rheumatology. 2004, 43: 1116-1120. 10.1093/rheumatology/keh274.CrossRefPubMed
18.
Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hegde PS, Loeser RF: NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol. 2005, 174: 5781-5788.PubMedCentralCrossRefPubMed
19.
Ding L, Guo D, Homandberg GA: Fibronectin fragments mediate matrix metalloproteinase upregulation and cartilage damage through proline rich tyrosine kinase 2, c-src, NF-kappaB and protein kinase Cdelta. Osteoarthritis Cartilage. 2009, 17: 1385-1392. 10.1016/j.joca.2009.03.024.CrossRefPubMed
20.
Lucic D, Mollenhauer J, Kilpatrick KE, Cole AA: N-telopeptide of type II collagen interacts with annexin V on human chondrocytes. Connect Tissue Res. 2003, 44: 225-239.CrossRefPubMed
21.
Jennings L, Wu L, King KB, Hämmerle H, Cs-Szabo G, Mollenhauer J: The effects of collagen fragments on the extracellular matrix metabolism of bovine and human chondrocytes. Connect Tissue Res. 2001, 42: 71-86. 10.3109/03008200109014250.CrossRefPubMed
22.
Fichter M, Körner U, Schömburg J, Jennings L, Cole AA, Mollenhauer J: Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes. J Orthop Res. 2006, 24: 63-70. 10.1002/jor.20001.CrossRefPubMed
23.
Guo D, Ding L, Homandberg GA: Telopeptides of type II collagen upregulate proteinases and damage cartilage but are less effective than highly active fibronectin fragments. Inflamm Res. 2009, 58: 161-169. 10.1007/s00011-009-8090-5.CrossRefPubMed
24.
Raveenthiran SP, Chowdhury TT: Dynamic compression inhibits fibronectin fragment induced iNOS and COX-2 expression in chondrocyte/agarose constructs. Biomech Model Mechanobiol. 2009, 8: 273-283. 10.1007/s10237-008-0134-1.CrossRefPubMed
25.
Lee DA, Bader DL: Compressive strains at physiological frequencies influence the metabolism of chondrocytes seeded in agarose. J Orthop Res. 1997, 15: 181-188. 10.1002/jor.1100150205.CrossRefPubMed
26.
Lee DA, Knight MM: Mechanical loading of chondrocytes embedded in 3D constructs: in vitro methods for assessment of morphological and metabolic response to compressive strain. Methods Mol Med. 2004, 100: 307-324.PubMed
27.
Schulz RM, Wüstneck N, van Donkelaar CC, Shelton JC, Bader A: Development and validation of a novel bioreactor system for load- and perfusion-controlled tissue engineering of chondrocyte-constructs. Biotechnol Bioeng. 2008, 101: 714-728. 10.1002/bit.21955.CrossRefPubMed
28.
Lee DA, Brand J, Salter DM, Akanji OO, Chowdhury TT: Quantification of mRNA using real-time PCR and western blot analysis of MAPK events in chondrocyte/agarose constructs. Methods Mol Med. 2010.
29.
Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group wise comparison and statistical analysis of relative expression results in real time PCR. Nucleic Acids Res. 2002, 30: e36-10.1093/nar/30.9.e36.PubMedCentralCrossRefPubMed
30.
Chowdhury TT, Bader DL, Lee DA: Dynamic compression inhibits the synthesis of nitric oxide and PGE2 by IL-1β stimulated chondrocytes cultured in agarose constructs. Biochem Biophys Res Commun. 2001, 285: 1168-1174. 10.1006/bbrc.2001.5311.CrossRefPubMed
31.
Chowdhury TT, Bader DL, Lee DA: Dynamic compression counteracts IL-1β induced release of nitric oxide and PGE 2 by superficial zone chondrocytes cultured in agarose constructs. Osteoarthritis Cartilage. 2003, 11: 688-696. 10.1016/S1063-4584(03)00149-3.CrossRefPubMed
32.
Jung M, Christgau S, Lukoschek M, Henriksen D, Richter W: Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology. 2004, 71: 70-76. 10.1159/000074419.CrossRefPubMed
33.
Carnemolla B, Cutolo M, Castellani P, Balza E, Raffanti S, Zardi L: Characterization of synovial fluid fibronectin from patients with rheumatic inflammatory diseases and healthy subjects. Arthritis Rheum. 1984, 27: 913-921. 10.1002/art.1780270811.CrossRefPubMed
34.
Jones KL, Brown M, Ali SY, Brown RA: An immunohistochemical study of fibronectin in human osteoarthritic and disease-free articular cartilage. Ann Rheum Dis. 1987, 46: 809-815. 10.1136/ard.46.11.809.PubMedCentralCrossRefPubMed
35.
Brown RA, Jones KL: Fibronectin synthesis and release in normal and OA human cartilage. Eur J Exp Musculoskel Res. 1992, 1: 25-32.
36.
Garnero P, Ayral X, Rousseau JC, Christgau S, Sandell LJ, Dougados M, Delmas PD: Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum. 2002, 46: 2613-2624. 10.1002/art.10576.CrossRefPubMed
37.
Felson DT, Kim YJ: The futility of current approaches to chondroprotection. Arthritis Rheum. 2007, 56: 1378-1383. 10.1002/art.22526.CrossRefPubMed
38.
Dieppe P: Disease modification in osteoarthritis: are drugs the answer?. Arthritis Rheum. 2005, 52: 1956-1959. 10.1002/art.21124.CrossRefPubMed
39.
Xie DL, Meyers R, Homandberg GA: Fibronectin fragments in osteoarthritic synovial fluid. J Rheumatol. 1992, 19: 1448-1452.PubMed
40.
Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR: Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997, 99: 1534-1545. 10.1172/JCI119316.PubMedCentralCrossRefPubMed
41.
Felice BR, Chichester CO, Barrach HJ: Type II collagen peptide release from rabbit articular cartilage. Ann NY Acad Sci. 1999, 878: 590-593. 10.1111/j.1749-6632.1999.tb07736.x.CrossRefPubMed
42.
Klatt AR, Paul-Klausch B, Klinger G, Kühn G, Renno JH, Banerjee M, Malchau G, Wielckens K: A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes. J Orthop Res. 2009, 27: 65-70. 10.1002/jor.20716.CrossRefPubMed
43.
Wu JJ, Lark MW, Chun LE, Eyre DR: Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem. 1991, 266: 5625-5628.PubMed
44.
Chowdhury TT, Bader DL, Shelton JC, Lee DA: Temporal regulation of chondrocyte metabolism in agarose constructs subjected to dynamic compression. Arch Biochem Biophys. 2003, 417: 105-111. 10.1016/S0003-9861(03)00340-0.CrossRefPubMed
45.
Jeffrey JE, Thomson LA, Aspden RM: Matrix loss and synthesis following a single impact load on articular cartilage in vitro. Biochim Biophys Acta. 1997, 1334: 223-232.CrossRefPubMed
46.
Valhmu WB, Stazzone EJ, Bachrach NM, Saed-Nejad F, Fischer SG, Mow VC, Ratcliffe A: Load-controlled compression of articular cartilage inducesa transient stimulation of aggrecan gene expression. Arch Biochem Biophys. 1998, 353: 29-36. 10.1006/abbi.1998.0633.CrossRefPubMed
47.
Ragan PM, Badger AM, Cook M, Chin VI, Gowen M, Grodzinsky AJ, Lark MW: Down-regulation of chondrocyte aggrecan and type-II collagen gene expression correlates with increases in static compression magnitude and duration. J Orthop Res. 1999, 17: 836-842. 10.1002/jor.1100170608.CrossRefPubMed
48.
De Croos JN, Dhaliwal SS, Grynpas MD, Pilliar RM, Kandel RA: Cyclic compressive mechanical stimulation induces sequential catabolic and anabolic gene changes in chondrocytes resulting in increased extracellular matrix accumulation. Matrix Biol. 2006, 25: 323-331. 10.1016/j.matbio.2006.03.005.CrossRefPubMed
49.
50.
Blain EJ, Mason DJ, Duance VC: The effect of cyclical compressive loading on gene expression in articular cartilage. Biorheology. 2003, 40: 111-117.PubMed
51.
Waldman SD, Couto DC, Grynpas MD, Pilliar RM, Kandel RA: A single application of cyclic loading can accelerate matrix deposition and enhance the properties of tissue-engineered cartilage. Osteoarthritis Cartilage. 2006, 14: 323-330. 10.1016/j.joca.2005.10.007.CrossRefPubMed
52.
Kisiday JD, Jin MS, DiMicco MA, Kurz B, Grodzinsky AJ: Effects of dynamic compressive loading on chondrocyte biosynthesis in self assembling peptide scaffolds. J Biomech. 2004, 37: 595-604. 10.1016/j.jbiomech.2003.10.005.CrossRefPubMed
53.
Wong M, Siegrist M, Cao X: Cyclic compression of articular cartilage explants is associated with progressive consolidation and altered expression pattern of extracellular matrix proteins. Matrix Biol. 1999, 18: 391-399. 10.1016/S0945-053X(99)00029-3.CrossRefPubMed
54.
Kisiday JD, Lee JH, Siparsky PN, Frisbie DD, Flannery CR, Sandy JD, Grodzinsky AJ: Catabolic responses of chondrocyte-seeded peptide hydrogel to dynamic compression. Ann Biomed Eng. 2009, 37: 1368-1375. 10.1007/s10439-009-9699-9.CrossRefPubMed
55.
Steinmeyer J, Ackermann B: The effect of continuously applied cyclic mechanical loading on the fibronectin metabolism of articular cartilage explants. Res Exp Med (Berl). 1999, 198: 247-260. 10.1007/s004330050108.CrossRef
56.
Bonassar LJ, Grodzinsky AJ, Srinivasan A, Davila SG, Trippel SB: Mechanical and physicochemical regulation of the action of insulin-like growth factor-I on articular cartilage. Arch Biochem Biophys. 2000, 379: 57-63. 10.1006/abbi.2000.1820.CrossRefPubMed
57.
Mauck RL, Nicoll SB, Seyhan SL, Ateshian GA, Hung CT: Synergistic action of growth factors and dynamic loading for articular cartilage tissue engineering. Tissue Eng. 2003, 9: 597-611. 10.1089/107632703768247304.CrossRefPubMed
58.
Ramage L, Nuki G, Salter DM: Signalling cascades in mechanotransduction: cell-matrix interactions and mechanical loading. Scand J Med Sci Sports. 2009, 19: 457-469. 10.1111/j.1600-0838.2009.00912.x.CrossRefPubMed
59.
Vincent TL, McLean CJ, Full LE, Peston D, Saklatvala J: FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. Osteoarthritis Cartilage. 2007, 15: 752-763. 10.1016/j.joca.2007.01.021.CrossRefPubMed
60.
Millward-Sadler SJ, Salter DM: Integrin-dependent signal cascades in chondrocyte mechanotransduction. Ann Biomed Eng. 2004, 32: 435-446. 10.1023/B:ABME.0000017538.72511.48.CrossRefPubMed
61.
Homandberg GA, Costa V, Wen C: Anti-Sense oligonucleotides to the alpha5 integrin subunit suppress cartilage chondrolytic activities of amino-terminal fibronectin fragments. Osteoarthritis Cartilage. 2001, 10: 381-393. 10.1053/joca.2002.0524.CrossRef
62.
Fitzgerald JB, Jin M, Dean D, Wood DJ, Zheng MH, Grodzinsky AJ: Mechanical compression of cartilage explants induces multiple time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP. J Biol Chem. 2004, 279: 19502-19511. 10.1074/jbc.M400437200.CrossRefPubMed
63.
Kurz B, Lemke A, Kehn M, Domm C, Patwari P, Frank EH, Grodzinsky AJ, Schünke M: Influence of tissue maturation and antioxidants on the apoptotic response of articular cartilage after injurious compression. Arthritis Rheum. 2004, 50: 123-130. 10.1002/art.11438.CrossRefPubMed
64.
Henrotin YE, Bruckner P, Pujol JP: The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage. 2003, 11: 747-755. 10.1016/S1063-4584(03)00150-X.CrossRefPubMed
65.
Chen CT, Bhargava M, Lin PM, Torzilli PA: Time, stress, and location dependent chondrocyte death and collagen damage in cyclically loaded articular cartilage. J Orthop Res. 2003, 21: 888-898. 10.1016/S0736-0266(03)00050-0.CrossRefPubMed
Metadata
Title
Biomechanical modulation of collagen fragment-induced anabolic and catabolic activities in chondrocyte/agarose constructs
Authors
Tina T Chowdhury
Ronny M Schulz
Sonpreet S Rai
Christian B Thuemmler
Nico Wuestneck
Augustinus Bader
Gene A Homandberg
Publication date
01-06-2010
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2010
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3009

Other articles of this Issue 3/2010

Arthritis Research & Therapy 3/2010 Go to the issue

Research article

Time to achieve remission determines time to be in remission

Review

Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Research article

Reduced trabecular bone mineral density and cortical thickness accompanied by increased outer bone circumference in metacarpal bone of rheumatoid arthritis patients: a cross-sectional study

Research article

Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice

Research article

Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts

Editorial

Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits